Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study
International Journal of Gynecology & Obstetrics · 2023-06 · 161 (3) · 751-759
DOI: 10.1002/ijgo.14635 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 09.01.2023. Verfasst von I-San Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Adenomyosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Wellcome Trust, CSY China-International Hepatitis Research Foundation, Ministry of Science and Technology.
Abstract (Originalsprache)
Objective
To investigate the safety and efficacy of adjuvant gonadotropin‐releasing hormone agonist (GnRH‐a) treatment followed by maintenance dienogest (DNG) therapy after uterus‐sparing surgery.
Methods
Retrospective cohort study. A total of 190 patients with severe adenomyosis underwent uterus‐sparing surgery between January 2010 and June 2020. Of these patients, 90 were analyzed. Forty‐six patients (control group) received adjuvant 6‐month GnRH‐a therapy alone after uterus‐sparing surgery, and 44 patients (maintenance group) received postoperative 6‐month GnRH‐a treatment followed by maintenance DNG therapy (2 mg/day orally). The median follow‐up period was 18 months. The study was analyzed using generalized estimating equations.
Results
At baseline, the characteristics of patients in each group were comparable. Compared with the control group, the maintenance group had a significant improvement in the visual analog scale score of dysmenorrhea ( P < 0.001), hemoglobin level ( P = 0.004), and uterine volume ( P = 0.004) from baseline to 18 months after uterus‐sparing surgery. The symptom recurrence rate was significantly lower in the maintenance group than in the control group (4.6% vs. 37.0%, P < 0.001).
Conclusions
The findings of this study suggest that combinatorial treatment with GnRH‐a (adjuvant treatment) and DNG (maintenance therapy) represents a safe and effective short‐term therapy after uterus‐sparing surgery for adenomyosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Obstetrics and Gynecology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Emergency Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Clinical Medicine, College of Medicine, National Yang-Ming University, Taipei, Taiwan.
ORCID-Profile: I-San Chan, Peng-Hui Wang, Yi-Jen Chen
Förderung
- Wellcome Trust
- CSY China-International Hepatitis Research Foundation
- Ministry of Science and Technology
- Taipei Veterans General Hospital
Zitieren
APA
Chan, I. S., Hsu, T. F., Shih, Y. C., Chang, Y. H., Wang, P. H., & Chen, Y. J. (2023). Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study. International Journal of Gynecology & Obstetrics, 161(3), 751-759. https://doi.org/10.1002/ijgo.14635
Vancouver
Chan IS, Hsu TF, Shih YC, Chang YH, Wang PH, Chen YJ. Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 2023;161(3):751-759. doi:10.1002/ijgo.14635
BibTeX
@article{Chan2023,
author = {Chan, I-San and Hsu, Teh-Fu and Shih, Ying-Chu and Chang, Yen-Hou and Wang, Peng-Hui and Chen, Yi-Jen},
title = {Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {161},
number = {3},
pages = {751--759},
doi = {10.1002/ijgo.14635}
}
EUVIMED